Log in to save to my catalogue

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related...

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3a88e4afff14cb6a4fc4d21da89f36f

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis

About this item

Full title

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis

Publisher

England: BioMed Central

Journal title

Molecular neurodegeneration, 2022-02, Vol.17 (1), p.13-13, Article 13

Language

English

Formats

Publication information

Publisher

England: BioMed Central

More information

Scope and Contents

Contents

One of the key pathological hallmarks of Alzheimer disease (AD) is the accumulation of the amyloid-β (Aβ) peptide into amyloid plaques. The apolipoprotein E (APOE) gene is the strongest genetic risk factor for late-onset AD and has been shown to influence the accumulation of Aβ in the brain in an isoform-dependent manner. ApoE can be produced by di...

Alternative Titles

Full title

Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f3a88e4afff14cb6a4fc4d21da89f36f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f3a88e4afff14cb6a4fc4d21da89f36f

Other Identifiers

ISSN

1750-1326

E-ISSN

1750-1326

DOI

10.1186/s13024-022-00516-0

How to access this item